project id: TCGA-KIRP; case submitter id: TCGA-DW-7841; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.85; rna integrity number: 9.1; age at index: 61; days to birth: -22403; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1949; age at diagnosis: 22403; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 445.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.8; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-DW-7841-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0;